COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?
Stefano Gelibter, Mario Orrico, Massimo Filippi, Lucia Moiola
Topics & Concepts
MedicineCladribineMultiple sclerosisAlemtuzumabSerologyNatalizumabVaccinationImmunologyInternal medicineSeroconversionRituximabAntibodyMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPolyomavirus and related diseases